Study Comparing Tutomesh® Repair to Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction
Tutomesh
Multicentric Prospective Randomized Study Comparing Technique of Tension-free Repair With Placement of a Bovine Pericardium Bioprosthesis (Tutopatch® and Tutomesh®) to Current Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction
1 other identifier
interventional
134
1 country
19
Brief Summary
This is a multicentric prospective randomized study comparing technique of tension-free repair with placement of a bovine pericardium bioprosthesis (Tutopatch® and Tutomesh®) to current conventional surgical techniques in potentially contaminated hernia repair and abdominal wall reconstruction. The hypothesis is that using Tutomesh® prostheses reduces the risk of postoperative complications at 30 days in the treatment of incisional hernias or complicated abdominal wall hernias (ref early complications) for potentially contaminated fields.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 2009
Typical duration for phase_3
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 19, 2010
CompletedFirst Posted
Study publicly available on registry
February 23, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedMarch 16, 2012
March 1, 2012
1.7 years
February 19, 2010
March 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
risk of postoperative complications: occurrence of complications related to pathology or surgery will be evaluated with the report of adverse events and emergency visits
30 days
Secondary Outcomes (4)
recurrence risk: Assessment of relapse thanks to emergency visits and to adverse events' report
1 year
the impact on postoperative pain: Assessment of postoperative pain by postponing analgesics
1 year
the socio-economic impact will be evaluated with the concomitant treatment and hospitalisations.
1 year
the impact on patients' quality of life: The evaluation of patient's quality of life will be done with the questionnaire quality of life SF12
1 year
Study Arms (2)
Tutomesh
EXPERIMENTALTechnique of abdominal wall reconstruction strengthened by Tutomesh®
conventional repair
ACTIVE COMPARATORConventional technique to repair incisional or abdominal wall hernias
Interventions
Conventional technique to repair potentially contaminated incisional or abdominal wall hernias
Technique of abdominal wall reconstruction or hernia repair strengthened by Tutomesh® in potentially contaminated environment.
Eligibility Criteria
You may qualify if:
- Patient presenting with an incisional hernia or complicated hernia contraindicating the use of non absorbable mesh:
- Infected incisional hernia: abdominal wall abscess, chronic fistula
- Incisional hernia with high septic potential: incisional hernia with strangulation of one or more intestinal loops, repair of incisional hernia during surgery requiring opening of the digestive tube (digestive resection, restoration of digestive continuity, gastro-intestinal perforation, peritonitis from digestive origin)
- Recurrent incisional hernia with problem of cutaneous healing
- Incisional hernia requiring important intestinal adhesiolysis
- Patients signing informed consent form after reading and understanding the information letter \_ Patients are more than 18 year old
You may not qualify if:
- Patient with major anesthetic risk (ASA 4)
- Patient suffering from immunodepression or under immunosuppressor treatment (corticoids…)
- Patients already enrolled in another study
- Patient suffering from severe disease not allowing a 1-year follow-up
- Patient refusing to be enrolled after consulting the information letter
- Patient presenting with a too large incisional hernia, superior to 140x200 mm
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (19)
CH Aix en Provence
Aix-en-Provence, 13616, France
CHU Amiens
Amiens, 80054, France
Ch Antibes-Juan les pins
Antibes, France
Clinique de la Casamance
Aubagne, 13400, France
CH Avignon
Avignon, 84900, France
CHG Beziers
Béziers, 34525, France
CHU Jean Verdier
Bondy, 93143, France
CHU Fréjus
Fréjus, 83600, France
CHU Grenoble
Grenoble - La Tronche, 38700, France
Hôpital Nord
Marseille, 13915, France
CH St Eloi
Montpellier, 34000, France
CHU Nantes
Nantes, France
CHU Archet II
Nice, 06202, France
CH Nimes
Nîmes, France
CHU Hôtel Dieu
Paris, 75004, France
CH Salon de Provence
Salon-de-Provence, 13658, France
CH Hautepierre
Strasbourg, 67200, France
CHU Rangueil
Toulouse, 31059, France
CHU Trousseau
Tours, 37000, France
Study Officials
- PRINCIPAL INVESTIGATOR
David Nocca, Dr
University Hospital, Montpellier
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. David NOCCA, CHRU Montpellier
Study Record Dates
First Submitted
February 19, 2010
First Posted
February 23, 2010
Study Start
January 1, 2009
Primary Completion
October 1, 2010
Study Completion
October 1, 2011
Last Updated
March 16, 2012
Record last verified: 2012-03